Shockwave Medical Inc (SWAV)
325.63
+3.02
(+0.94%)
USD |
NASDAQ |
Mar 28, 16:00
328.00
+2.37
(+0.73%)
After-Hours: 20:00
Shockwave Medical Max Drawdown (5Y): 64.92% for Feb. 29, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
February 29, 2024 | 64.92% |
January 31, 2024 | 64.92% |
December 31, 2023 | 64.92% |
November 30, 2023 | 64.92% |
October 31, 2023 | 64.92% |
September 30, 2023 | 64.92% |
August 31, 2023 | 64.92% |
July 31, 2023 | 64.92% |
June 30, 2023 | 64.92% |
May 31, 2023 | 64.92% |
April 30, 2023 | 64.92% |
March 31, 2023 | 64.92% |
February 28, 2023 | 64.92% |
January 31, 2023 | 64.92% |
December 31, 2022 | 64.92% |
November 30, 2022 | 64.92% |
October 31, 2022 | 64.92% |
September 30, 2022 | 64.92% |
August 31, 2022 | 64.92% |
July 31, 2022 | 64.92% |
June 30, 2022 | 64.92% |
May 31, 2022 | 64.92% |
April 30, 2022 | 64.92% |
March 31, 2022 | 64.92% |
February 28, 2022 | 64.92% |
Date | Value |
---|---|
January 31, 2022 | 64.92% |
December 31, 2021 | 64.92% |
November 30, 2021 | 64.92% |
October 31, 2021 | 64.92% |
September 30, 2021 | 64.92% |
August 31, 2021 | 64.92% |
July 31, 2021 | 64.92% |
June 30, 2021 | 64.92% |
May 31, 2021 | 64.92% |
April 30, 2021 | 64.92% |
March 31, 2021 | 64.92% |
February 28, 2021 | 64.92% |
January 31, 2021 | 64.92% |
December 31, 2020 | 64.92% |
November 30, 2020 | 64.92% |
October 31, 2020 | 64.92% |
September 30, 2020 | 64.92% |
August 31, 2020 | 64.92% |
July 31, 2020 | 64.92% |
June 30, 2020 | 64.92% |
May 31, 2020 | 64.92% |
April 30, 2020 | 64.92% |
March 31, 2020 | 64.92% |
February 29, 2020 | 55.47% |
January 31, 2020 | 55.47% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
15.75%
Minimum
Mar 2019
64.92%
Maximum
Mar 2020
59.96%
Average
64.92%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
AtriCure Inc | 63.61% |
Insulet Corp | 61.31% |
Perspective Therapeutics Inc | 91.70% |
Xtant Medical Holdings Inc | 98.66% |
Asensus Surgical Inc | 99.68% |